References
- Ferreyro BL, Angriman F, Munshi L, et al. Association of Noninvasive Oxygenation Strategies With All-Cause Mortality in Adults With Acute Hypoxemic Respiratory Failure: A Systematic Review and Meta-analysis. JAMA: The Journal of the American Medical Association. 2020;324(1):57–67. doi:10.1001/jama.2020.9524.
- Bellani G, Laffey JG, Pham T, ESICM Trials Group, et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016;315(8):788–800. doi:10.1001/jama.2016.0291.
- Urner M, Jüni P, Hansen B, Wettstein MS, Ferguson ND, Fan E. Time-varying intensity of mechanical ventilation and mortality in patients with acute respiratory failure: a registry-based, prospective cohort study. Lancet Respir Med. 2020;8(9):905–913. doi:10.1016/S2213-2600(20)30325-8.
- Armstrong RA, Kane AD, Cook TM. Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies. Anaesthesia. 2020;75(10):1340–1349. doi:10.1111/anae.15201.
- Goligher EC, Tomlinson G, Hajage D, et al. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial. JAMA: The Journal of the American Medical Association. 2018;320(21):2251–2259. doi:10.1001/jama.2018.14276.
- Combes A, Peek GJ, Hajage D, et al. ECMO for severe ARDS: systematic review and individual patient data meta-analysis. Intensive Care Med. 2020;46(11):2048–2057. doi:10.1007/s00134-020-06248-3.
- Combes A, Hajage D, Capellier G, EOLIA Trial Group, REVA, and ECMONet, et al. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. N Engl J Med. 2018;378(21):1965–1975. doi:10.1056/NEJMoa1800385.
- Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374(9698):1351–1363. doi:10.1016/S0140-6736(09)61069-2.
- Barbaro RP, MacLaren G, Boonstra PS, Extracorporeal Life Support Organization, et al. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry. Lancet. 2020;396(10257):1071–1078. doi:10.1016/S0140-6736(20)32008-0.
- Villar J, Ferrando C, Martínez D, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8(3):267–276. doi:10.1016/S2213-2600(19)30417-5.
- Horby P, Lim WS, Emberson JR, et al. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. The New England Journal of Medicine. 2020;384(8):693–704.
- Siemieniuk RA, Bartoszko JJ, Ge L, et al. Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ. 2020;370:m2980 doi:10.1136/bmj.m2980.
- Sterne JAC, Murthy S, Diaz JV, The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020;324(13):1330–1341. doi:10.1001/jama.2020.17023.
- Hernández G, Ospina-Tascón GA, Damiani LP, The ANDROMEDA SHOCK Investigators and the Latin America Intensive Care Network (LIVEN), et al. Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial. JAMA: The Journal of the American Medical Association. 2019;321(7):654–664. doi:10.1001/jama.2019.0071.
- Lamontagne F, Richards-Belle A, Thomas K, for the 65 trial investigators, et al. Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical Trial. JAMA: The Journal of the American Medical Association. 2020;323(10):938–949. doi:10.1001/jama.2020.0930.
- Fowler AA, Truwit JD, Hite RD, et al. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial. JAMA: The Journal of the American Medical Association. 2019;322(13):1261–1270. doi:10.1001/jama.2019.11825.
- Moskowitz A, Huang DT, Hou PC, ACTS Clinical Trial Investigators, et al. Effect of Ascorbic Acid, Corticosteroids, and Thiamine on Organ Injury in Septic Shock: The ACTS Randomized Clinical Trial. JAMA: The Journal of the American Medical Association. 2020;324(7):642–650. doi:10.1001/jama.2020.11946.
- Sherbrooke Ud, Lotte, Foundation JHM. Lessening Organ Dysfunction With VITamin C. Web site. https://ClinicalTrials.gov/show/NCT03680274. ; 2018.
- Gaudry S, Hajage D, Benichou N, et al. Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials. The Lancet. 2020;395(10235):1506–1515. doi:10.1016/S0140-6736(20)30531-6.
- Bagshaw SM, Wald R, Adhikari NKJ, et al. Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. The New England Journal of Medicine. 2020;383(3):240–251.
- Greer DM, Shemie SD, Lewis A, et al. Determination of Brain Death/Death by Neurologic Criteria: The World Brain Death Project. JAMA. 2020;324(11):1078–1097. Sep 15: American Medical Association; doi:10.1001/jama.2020.11586.
- Kapur J, Elm J, Chamberlain JM, NETT and PECARN Investigators, et al. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus. N Engl J Med. 2019;381(22):2103–2113. doi:10.1056/NEJMoa1905795.]